Volume Pricing
Research Overview
Tirzepatide is a synthetic peptide engineered to act as a dual agonist at both the GIP and GLP-1 receptors. It is a benchmark compound in modern metabolic and glucose-regulation research.
Preclinical and clinical research has examined tirzepatide across glycemic-control, body-composition, and satiety endpoints, making it one of the most referenced dual-incretin compounds in metabolic-research models.
Research Focus
Mechanism (Research Context)
Tirzepatide is studied for its simultaneous activation of the GIP and GLP-1 receptors, a combination observed to influence insulin secretion, satiety signaling, and energy balance in research models.
Intended Use
This compound is strictly intended for in vitro laboratory research. It is not for use in humans or animals. Not to be used in foods, drugs, or medical diagnostics.
Legal Disclaimer
This product has not been evaluated by the FDA. It is not intended to diagnose, treat, cure, or prevent any disease. Usage is restricted to certified laboratories and qualified research professionals.
Terms of Sale
All sales by Codex Research are final. Buyers must be qualified professionals and assume full responsibility for safe handling and regulatory compliance. Every batch is independently verified by accredited third-party laboratories. Batch-specific Certificates of Analysis are available on our COAs page.
For Research Use Only · Not for Human Consumption






















Reviews
There are no reviews yet.